Search results for "Relations"

showing 10 items of 6949 documents

Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.

2007

Objectives: The intratympanic application of a low dosage of gentamicin is increasingly favored as treatment for Meniere's disease. While posttreatment observations have confirmed a long-term success of the therapy of vertigo attacks, clear differences in the posttreatment recovery interval can be observed. In addition to differences in central-vestibular compensation, the degree of peripheral vestibular damage, i.e., to the saccule, utricle, and semicircular canal ampullae, varies among patients. This study provides comprehensive pre- and posttreatment results from unilateral functional tests of the individual vestibular receptors and of the cochlea in patients with Meniere's disease. Stud…

AdultMalemedicine.medical_specialtyTympanic MembraneVestibular evoked myogenic potentialAdministration TopicalOtolithic MembraneUtricleVertigootorhinolaryngologic diseasesmedicineHumansProspective StudiesMeniere DiseaseAntibacterial agentAgedVestibular systemSemicircular canalbiologyDose-Response Relationship Drugbusiness.industryElectromyographymedicine.diseasebiology.organism_classificationSurgeryAnti-Bacterial Agentsmedicine.anatomical_structureTreatment OutcomeOtorhinolaryngologyAnesthesiaEvoked Potentials AuditoryFemalesense organsSacculeGentamicinsbusinessMeniere's diseaseFollow-Up StudiesThe Laryngoscope
researchProduct

Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant

2009

We assessed the efficacy and outcome of low through level of calcineurin inhibitors (CNI) and introducing mycophenolate mofetil (MMF) in liver transplant (LT) patients with CNI-related renal dysfunction. Thirty LT patients were converted to combined therapy and compared with 30 patients used as a contemporary control group receiving CNI only. The two groups were matched for sex, age, months after LT, immunosuppressive treatment, creatinine level, presence of diabetes and calculated glomerular filtration rate (GFR) via Cockroft-Gault method. After two years, in the MMF serum creatinine decreased from 1.65 mg/dL (range 1.33-3.5) to 1.4 mg/dL (range 0.9-4.7) (p = 0.002) and GFR increased from …

AdultMalemedicine.medical_specialtyUrinary systemmedicine.medical_treatmentCalcineurin InhibitorsUrologyRENAL DYSFUNCTIONRenal functionCALCINEURIN INHIBITORS; IMMUNOSUPPRESSION; LIVER TRANSPLANTATION; MYCOPHENOLATE MOFETIL; RENAL DYSFUNCTIONLiver transplantationKidney Function TestsTacrolimusMycophenolic acidNephrotoxicitychemistry.chemical_compoundmedicineHumansMYCOPHENOLATE MOFETILAgedTransplantationCreatinineIMMUNOSUPPRESSIONDose-Response Relationship Drugbusiness.industryGraft SurvivalMiddle AgedMycophenolic AcidTacrolimusLiver TransplantationCalcineurinliver transplantTreatment OutcomechemistryCreatinineImmunologyKidney Failure ChronicDrug Therapy CombinationFemalebusinessImmunosuppressive AgentsGlomerular Filtration Ratemedicine.drug
researchProduct

Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care

2017

Medication non adherence in schizophrenia is a major cause of relapse and hospitalization and remains for clinicians an important challenge. This study investigates the associations between insight, therapeutic alliance, perceived trauma related to psychiatric treatment and medication adherence in patients with schizophrenia. In this multicenter study, 72 patients were assessed regarding symptomatology, self-reported adherence with medication, insight, medication side-effects, therapeutic alliance and perceived trauma related to psychiatric treatment. Structural Equation Modeling (SEM) was used to test predicted paths among these variables. The data fit a model in which medication adherence…

AdultMalemedicine.medical_specialty[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyMedication adherencePsychological TraumaStructural equation modelingMedication Adherence[ SDV.NEU.PC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior03 medical and health sciences[ SDV.NEU.SC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences0302 clinical medicineMedicineHumansIn patientPsychiatryBiological PsychiatryComputingMilieux_MISCELLANEOUS[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behaviorbusiness.industry[SCCO.NEUR]Cognitive science/Neuroscience[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesProfessional-Patient RelationsAwarenessMiddle Agedmedicine.diseaseMental healthNon adherence030227 psychiatry3. Good healthPsychiatry and Mental healthAllianceMulticenter studySchizophrenia[ SDV.NEU.NB ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology[ SCCO.NEUR ] Cognitive science/NeuroscienceSchizophreniaFemalebusiness030217 neurology & neurosurgeryClinical psychologyAntipsychotic Agents
researchProduct

Mid-Term Effectiveness of Behavioral and Psychodynamic Inpatient Treatments of Severe Obesity Based on a Randomized Study

2006

<i>Background:</i> The objective of this study was to compare the effectiveness of psychodynamic and behavioral inpatient treatments of severely obese patients regarding weight and distress. <i>Methods:</i> In a longitudinal study obese patients (body mass index, BMI ≧35) were randomly assigned to behavioral or to psychodynamic inpatient treatment. Mostly female (n = 267; 85%) obese patients with psychiatric and somatic comorbidity (age 20–64 years, BMI 35–74) were examined with standardized self-report scales on distress (SCL-90R), interpersonal problems (Inventory of Interpersonal Problems), eating behavior (Fragebogen zum Essverhalten) and body image (Fragebogen z…

AdultMalemedicine.medical_specialtymacromolecular substancesBody weightSeverity of Illness IndexBody Mass Indexlaw.inventionPsychiatric comorbidityRandomized controlled trialBehavior TherapylawSurveys and QuestionnairesmedicineHumansInterpersonal RelationsObesityBulimia NervosaPsychiatryApplied PsychologyApplication methodsbusiness.industryFollow up studiesGeneral MedicineMiddle AgedSevere obesityPsychodynamicsmedicine.diseaseObesityHospitalizationPsychotherapyPsychiatry and Mental healthClinical PsychologyFemalebusinessFollow-Up StudiesPsychotherapy and Psychosomatics
researchProduct

Impact of Empathy in the Patient-Doctor Relationship on Chronic Pain Relief and Quality of Life: A Prospective Study in Spanish Pain Clinics.

2017

Objective To assess the impact of the empathy of physicians, perceived by patients with chronic pain, regarding pain relief and health-related quality of life (HR-QoL). Methods A prospective noninterventional study was conducted in 2,898 patients with moderate to severe chronic pain who were referred to pain clinics. The same physician visited each patient at baseline and after one and three months. Study questionnaires included the Jefferson Scale of Patient Perceptions of Physician Empathy (JSPPPE), the Life Orientation Test-Revised (LOT-R), the Pain Coping Questionnaire (CAD-R), the Brief Pain Inventory Short Form (BPI-SF), and the EuroQol-5D (EQ-5D). Regression analyses were used to eva…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectEmpathyBrief Pain Inventory Short FormCohort Studies03 medical and health sciences0302 clinical medicineQuality of lifemedicineHumansPain Management030212 general & internal medicineProspective StudiesProspective cohort studymedia_commonAgedPhysician-Patient Relationsbusiness.industryChronic painGeneral MedicineMiddle Agedmedicine.diseaseAnesthesiology and Pain MedicinePain ClinicsSpainPhysical therapyQuality of LifePain ClinicsPain catastrophizingFemaleNeurology (clinical)Chronic PainEmpathybusiness030217 neurology & neurosurgeryCohort studyFollow-Up Studies
researchProduct

Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres

2017

Background and purpose Receiving clear, complete and up-to-date information and having a satisfying relationship with the health professional (HP) are of primary importance for MS patients. Healthcare organization plays a key role in promoting an effective relationship and communication between patients and HPs. The present study aims to explore which care organization and service characteristics provided by Italian MS centres best predict patients’ satisfaction with healthcare. Methods Eighty-one centres and 707 patients (502 women, mean age 40.5 years, SD 10.2; mean education 12.2 years, SD 3.6; time since diagnosis 5.9 years, SD 1.5) were included in the analysis. The care organization a…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectPsychological interventionNicehealth professional-patient relationshipmultiple sclerosiscare organization; health professional-patient relationship; multiple sclerosis; patients’ satisfaction; psychological support03 medical and health sciences0302 clinical medicinePatient satisfactionCare organizationExcellenceSurveys and QuestionnairesHealth caremedicineHumans030212 general & internal medicinepatients’ satisfactioncomputer.programming_languagemedia_commonPhysician-Patient Relationsbusiness.industryMultiple sclerosisMiddle Agedmedicine.diseaseConfidence intervalItalyNeurologyPatient SatisfactionFamily medicineFemalecare organizationNeurology (clinical)businessDelivery of Health CareCare Organization Health professional–Patient Relationship Multiple Sclerosis Patients’ Satisfaction Psychological Supportcomputer030217 neurology & neurosurgerypsychological supportEuropean Journal of Neurology
researchProduct

Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia

1993

It was the aim of this study to investigate the antileukemic activities of recombinant interferon beta (rIFN beta) in chronic-phase CML in vitro and in vivo. Nine patients in the early chronic-phase of CML were treated in a phase-II trial with escalating doses of rIFN beta. In parallel, antiproliferative and immunomodulatory activities of rIFN beta and rIFN alpha 2b were studied in vitro. rIFN beta exhibited a significantly higher antiproliferative activity on hematopoietic progenitor cells of CML patients in vitro than rIFN alpha 2b. In contrast, only very limited clinical antileukemic efficacy of rIFN beta was observed. None of the patients achieved a complete or partial hematologic respo…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAlpha (ethology)Interferon alpha-2PharmacologyNeopterinIn vivoInternal medicineHumansMedicineBeta (finance)AgedHematologyDose-Response Relationship Drugbusiness.industryInterferon-alphaInterferon-betaHematologyGeneral MedicineImmunotherapyMiddle AgedReceptor antagonistmedicine.diseaseBiopterinRecombinant ProteinsCytokineGenesLeukemia Myeloid Chronic-PhaseImmunologyFemaleInterferonsbeta 2-MicroglobulinbusinessChronic myelogenous leukemiaAnnals of Hematology
researchProduct

Laboratory control of minimal heparinization during haemodialysis in patients with a risk of haemorrhage

1994

Abstract For patients undergoing dialysis with a high risk of haemorrhage there is no standardized procedure for anticoagulation during extracorporeal circulation. Minimal heparinization with a dose equivalent to half that used for chronic haemodialysis was employed in 49 patients (125 haemodialyses) performed after operative interventions (83.3%), after haemorrhagic events (5.2%) and after invasive investigations (11.5%). Using a biocompatible membrane and a low molecular weight heparin (bolus dose 500-1300 U; continuous infusion 100-400 U) it was possible to complete haemodialysis in 74 cases (Group 0) without clots appearing in the venous bubble trap of the tubing system. In 30 cases (Gr…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentAntithrombin IIILow molecular weight heparinHemorrhageFibrin Fibrinogen Degradation ProductsClinical ProtocolsRenal DialysisRisk FactorsmedicineHumansIn patientRisk factorDialysisAgedMonitoring PhysiologicDose-Response Relationship Drugbusiness.industryAnticoagulantExtracorporeal circulationHematologyGeneral MedicineHeparinHeparin Low-Molecular-WeightMiddle AgedAntifibrinolytic AgentsSurgeryFemaleHemodialysisbusinessPeptide Hydrolasesmedicine.drugBlood Coagulation & Fibrinolysis
researchProduct

Nonlinear pharmacokinetics of fluvoxamine and gender differences.

1998

This prospective study assessed fluvoxamine serum concentrations under two different fixed doses. The study included 15 male and female patients who met the DSM-III-R criteria for major depression. They were prescribed 50 mg fluvoxamine twice a day for 2 weeks and 100 mg twice a day thereafter. Drug monitoring was carried out on days 14 and 28. Fluvoxamine serum concentrations were highly variable between patients. After the dose was doubled, the serum concentrations of fluvoxamine increased disproportionately (mean, 3.4-fold), and there was a significantly (p < 0.05) more pronounced increase in men (4.6-fold) than in women (2.4-fold). These results provide evidence of nonlinear, sex-depend…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentFluvoxamineGastroenterologySex FactorsPharmacokineticsOral administrationInternal medicinemedicineHumansPharmacology (medical)Prospective StudiesProspective cohort studyAgedPharmacologyAged 80 and overChemotherapyDepressive DisorderDose-Response Relationship Drugbusiness.industryNonlinear pharmacokineticsMiddle AgedDose–response relationshipFluvoxamineAnesthesiaAntidepressive Agents Second-GenerationFemalebusinessReuptake inhibitormedicine.drugTherapeutic drug monitoring
researchProduct

Efficacy and tolerability of multiple-dose SDZ IMM 125 in patients with severe psoriasis.

2006

Although cyclosporin is effective in immunosuppression following organ transplantation and in the treatment of psoriasis, its use is limited by its side-effects, notably impaired renal function and hypertension. As SDZ IMM 125, a new derivative of the cyclosporin family, showed considerable immunosuppressive activity in experimental studies, with less effect on renal function, it was considered a potential successor to cyclosporin for both indications. In this multicentre, double-blind, placebo-controlled study, the efficacy and tolerability of 40, 100, 200 and 400 mg SDZ IMM 125 daily were studied in 59 patients with psoriasis. Patients were followed for a period of 5 weeks (4 weeks treatm…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRenal functionCyclosporinsDermatologyPharmacologyGastroenterologyDrug Administration ScheduleDouble-Blind MethodInternal medicinePsoriasismedicineHumansPsoriasisAdverse effectBody surface areaChemotherapyDose-Response Relationship Drugbusiness.industryImmunosuppressionMiddle Agedmedicine.diseaseTolerabilityToxicityFemalebusinessImmunosuppressive AgentsFollow-Up StudiesThe British journal of dermatology
researchProduct